The Role of the JC Virus in Central Nervous System Tumorigenesis

Nicholas Ahye1, Anna Bellizzi1, Dana May1

  • 1Center for Neurovirology, Department of Neuroscience, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.

Insights

The JC virus (JCV) is linked to central nervous system (CNS) tumors in animal models. While prevalent in humans, its direct role in human CNS cancer initiation remains unclear.

Area of Science:

  • Neuroscience
  • Oncology
  • Virology

Background:

  • Cancer is a leading global cause of death, with DNA tumor viruses playing a role in oncogenesis.
  • The human neurotropic Polyomavirus JC (JCV), prevalent in 85% of the population, causes progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals.
  • JCV's persistence and cell-transforming potential make it a focus for brain tumor research.

Purpose of the Study:

  • To review the correlation between JCV and central nervous system (CNS) tumorigenesis in animal models.
  • To provide an overview of current evidence regarding JCV's role in human brain tumor formation.
  • To explore the hypothesis that JCV may contribute to CNS tumorigenesis.

Main Methods:

  • Review of existing scientific literature and studies.
  • Analysis of observations in progressive multifocal leukoencephalopathy (PML) cases.
  • Examination of findings from non-human primate studies inoculated with JCV.

Main Results:

  • JCV has been detected in some primary human brain tumor specimens.
  • JCV can induce tumors in animal models, suggesting a potential causative role in CNS tumorigenesis.
  • Malignant astrocytes and oligodendrocytes observed in PML, alongside glioblastoma in primates, support the JCV-CNS tumor hypothesis.

Conclusions:

  • Current evidence suggests JCV can be a causative factor in CNS tumorigenesis, particularly based on animal model data.
  • A definitive association between JCV presence in the human CNS and the initiation of CNS cancer is not yet established.
  • Further research is needed to clarify JCV's precise role in human brain tumor development.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K